TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
NanoVibronix ( (NAOV) ) has provided an announcement.
On July 18, 2025, NanoVibronix, Inc. entered into a Securities Purchase Agreement with an institutional investor to sell Series H Convertible Preferred Stock and warrants, raising $8 million in gross proceeds. The company plans to use $5 million to redeem outstanding shares of its Series X Preferred Stock and the remainder for working capital. This agreement, which includes provisions for additional future investments, aims to strengthen NanoVibronix’s financial position and support its operational growth.
More about NanoVibronix
NanoVibronix, Inc. operates in the medical device industry, focusing on developing non-invasive, portable therapeutic ultrasound devices. The company’s primary products include devices designed to treat pain, wounds, and other medical conditions, with a market focus on enhancing patient care through innovative technology.
Average Trading Volume: 4,949,205
Technical Sentiment Signal: Sell
Current Market Cap: $2.61M
For detailed information about NAOV stock, go to TipRanks’ Stock Analysis page.